RONALD J. HABERMAN, M.D.

Huntington, WV 25705 (C) 304-690-2012 RonaldHaberman@gmail.com

PROFESSIONAL OBJECTIVE
An entrepreneurial and driven Electrophysiologist searching for a Medical Director position within the pharmaceutical industry where it would be possible to leverage medical practice history, clinical trial experience, and extensive technical and medical knowledge.

PROFESSIONAL SUMMARY
A creative thinker with a track record of leadership in cardiac electrophysiology practice with extensive antiarrhythmic and anticoagulant drug experience. Has performed at all levels of clinical research and trial projects, having carried out bench research, designed protocols, served as primary site investigator, and delivered presentations at national meetings (HRS, ACC, AHA). Authored numerous manuscripts and publications including a chapter in the well-known Lange Medical Book Series: Current Diagnosis & Treatment in Cardiology. In addition, contributed to various research papers in the areas of electrophysiology, encompassing arrhythmias, defibrillation and antiarrhythmic drugs. Speaks on behalf of and recognized as a key opinion leader (KOL) by top pharmaceutical and medical device companies on the basis of clinical use and knowledge of cardioactive and antiarrhythmic drug mechanisms plus high device implantation and cardiac ablation volume (>6,000 cumulative procedures). A passionate and meticulous medical writer who possesses an exceptional aptitude for absorbing new information, a high comfort level in presenting technical data both live and in print media, and an ability to easily translate medical information for comprehension by nonmedical audiences. Has trained and educated medical teams and enjoys a standing practice rotation with an accredited Pharmacy residency program. Has additional experience as a Clinical Instructor for prestigious institutions including The Johns Hopkins University School of Medicine, Sinai Hospital of Baltimore, and the Medical College of Pennsylvania. Equally comfortable working independently or as part of a project development team.

PROFESSIONAL CORE COMPETENCIES

20+ years practicing medicine as a Clinical Cardiac Electrophysiologist with a focus on antiarrhythmic and antithrombotic drugs Board Certified in Clinical Cardiac Electrophysiology, Cardiovascular Diseases, and Internal Medicine Clinical Instructor with training and education of physicians, residents, fellows, and clinical staff; ongoing pharmacy residency rotation Ability to translate and effectively present medical information for comprehension by non-medical audiences Prior site investigator (IV amiodarone and others), protocol design, manuscript writing, peer-review publication, and bench research KOL, communicator, and presenter at national pharmaceutical and medical device seminars Medical writing experience includes authoring a textbook chapter, manuscripts, and publications 15+ years of working with complex medical device technology including pacemakers and defibrillators

PROFESSIONAL EXPERIENCE
HUNTINGTON INTERNAL MEDICINE GROUP (HIMG); Huntington, WV

HIMG is the largest medical specialty group in West Virginia with physicians most medical and surgical specialties. Upon his arrival in 2007, Dr. Haberman started the HIMG Arrhythmia Center, which rapidly grew into a thriving and very profitable cost center. His focus on practice efficiency helped keep expenditures, including labor costs, to a minimum. MERCY ARRHYTHMIA CONSULTANTS; Rogers, AR 2004 - 2007

Clinical Cardiac Electrophysiologist

2007 - 2013

Mercy Arrhythmia Consultants is part of a large, hospital-run system. Dr. Haberman was the first electrophysiologist employed by Mercy and helped build the hospitals electrophysiology laboratory and was instrumental in putting associated policies and procedures in place. Also sat on the EHR selection committee. HEART CARE RHYTHM ASSOCIATES; Joplin, MO 2003 - 2004

Clinical Cardiac Electrophysiologist

Heart Care Rhythm Associates was formed Dr. Habermans after the dissolution of the group he was with previously. HEART CARE & SURGICAL ASSOCIATES; Joplin, MO 1999 - 2002

Solo Clinical Cardiac Electrophysiologist

Clinical Cardiac Electrophysiologist

Dr. Haberman was the first electrophysiologist to join Heart Care & Surgical Associates, the regions largest, most wellestablished, and most successful team of cardiologists and cardiothoracic surgeons. He started the cardiac ablation program and more than doubled the number of device implantations previously performed by the group. In addition, the addition of inhouse arrhythmia monitoring introduced a new and profitable revenue stream to the group. SOUTHWEST ARRHYTHMIA CONSULTANTS; Scottsdale, AZ 1994 - 1998

Shortly after finishing his training, Dr. Haberman formed Southwest Arrhythmia Consultants. He penetrated the previously-untouched periphery of Phoenix/Scottsdale, working with several of the outlying regional hospitals to help them open electrophysiology laboratories. Using a combination of keen business savvy and personal skills, he developed a booming practice within 6 months. EDUCATION RUSH MEDICAL COLLEGE; M.D. Chicago, IL. 1984. STATE UNIVERISTY OF NEW YORK AT STONY BROOK; B.S. Biology. Stony Brook, NY. 1978. POST-GRADUATE TRAINING THE LANKENAU HOSPITAL; Cardiology/Electrophysiology Fellowship. Wynnewood, PA. 1993 SINAI HOSPITAL OF BALTIMORE; Internal Medicine Residency and Chief Residency; Baltimore, MD. 1988 MOUNTAINSIDE HOSPITAL; Internal Medicine Internship; Montclair, NJ. 1985

Solo Clinical Cardiac Electrophysiologist

PUBLICATIONS CHAPTERS 1. 2. 3. 4. 5. 6. 7. "Supraventricular tachycardias." In Current Diagnosis & Treatment in Cardiology, Michael H. Crawford, Editor. Appleton & Lange, 1995. Haberman RJ, Steinhaus DM. Can an encircling atrial cryoablation lesion during bypass surgery prevent atrial fibrillation? Submitted. Haberman RJ, Rials SJ, Stohler JL, Marinchak RA, Kowey PR. Evidence for a re-excitability gap in man after treatment with type I antiarrhythmic drugs. Am Heart J 126(5):1121-1126;1993. Haberman RJ, Kowey PR, Marinchak RA, Rials SJ. Abnormal ECG: pacemaker failure? Choices in Cardio, March-April, 1992. Haberman RJ, Kowey PR, Marinchak RA, Rials SJ. VT vs SVT. Choices in Cardiol 5(2):57-58;1991. Haberman RJ, Veltri EP, Mower MM. The effect of amiodarone on defibrillation threshold. J Electrophysiol 2:415-423;1988. Haberman RJ, Ladenson PW, Griffith LSC, Aarons D, Veltri EP. Serum reverse T3 and amiodarone efficacy. Clin Cardiol 12:140-144;1989.

ABSTRACTS 1. 2. 3. 4. 5. Kowey PR, Haberman RJ, Rials SJ, Stohler JL, Marinchak RA. Evidence for a re-excitability gap in man after treatment with type I drugs. PACE 15(II):552;1992. Haberman RJ, Veltri EP, Mower MM. The effect of amiodarone on defibrillation threshold. PACE 10:406;1987 Mower MM, Haberman RJ, and Veltri EP. Drug increase in defibrillation energy requirement. In: Proceedings of the 40th Annual Conference on Engineering in Medicine and Biology, September 10-13, 1987, Niagara Fall, NY. The correlation between left ventricular mass and defibrillation threshold. Presented at the American College of Physicians Maryland Region Associates Meeting, May 18, 1988, Baltimore, MD. Evidence for a re-excitability gap in man after treatment with type I drugs. Presented at the North American Society of Pacing and Electrophysiology 13th Annual Scientific Session, May 16, 1992, Chicago, IL.

LETTERS 1. Haberman RJ, Veltri EP. LV mass and defibrillation threshold. American Heart Journal 115:1340;1988 NATIONAL PRESENTATIONS 1. 2. 3. Amiodarone affects defibrillation threshold. Presented at the National Meeting of the American Federation of Clinical Research, April 30- May 4, 1987, San Diego, CA. The effect of amiodarone on defibrillation threshold. Presented as part of the Young Investigator Award Competition at the North American Society of Pacing and Electrophysiology 8th Annual Scientific Session, May 1, 1987, Boston, MA. Serum reverse T3 and amiodarone efficacy. Presented at the American College of Physicians Maryland Region Associates Meeting, May 18, 1988, Baltimore, MD